Cancer immunoediting and resistance to T cell-based immunotherapy

JS O'Donnell, MWL Teng, MJ Smyth - Nature reviews Clinical oncology, 2019 - nature.com
Anticancer immunotherapies involving the use of immune-checkpoint inhibitors or adoptive
cellular transfer have emerged as new therapeutic pillars within oncology. These treatments …

Osteoimmunology: evolving concepts in bone–immune interactions in health and disease

M Tsukasaki, H Takayanagi - Nature Reviews Immunology, 2019 - nature.com
In terrestrial vertebrates, bone tissue constitutes the 'osteoimmune'system, which functions
as a locomotor organ and a mineral reservoir as well as a primary lymphoid organ where …

The TNF family of ligands and receptors: communication modules in the immune system and beyond

C Dostert, M Grusdat, E Letellier… - Physiological …, 2019 - journals.physiology.org
The tumor necrosis factor (TNF) and TNF receptor (TNFR) superfamilies (TNFSF/TNFRSF)
include 19 ligands and 29 receptors that play important roles in the modulation of cellular …

Osteoimmunology: the conceptual framework unifying the immune and skeletal systems

K Okamoto, T Nakashima, M Shinohara… - Physiological …, 2017 - journals.physiology.org
The immune and skeletal systems share a variety of molecules, including cytokines,
chemokines, hormones, receptors, and transcription factors. Bone cells interact with immune …

[HTML][HTML] Stem cells and the differentiation hierarchy in mammary gland development

NY Fu, E Nolan, GJ Lindeman… - Physiological …, 2020 - journals.physiology.org
The mammary gland is a highly dynamic organ that undergoes profound changes within its
epithelium during puberty and the reproductive cycle. These changes are fueled by …

RANKL biology: bone metabolism, the immune system, and beyond

T Ono, M Hayashi, F Sasaki, T Nakashima - Inflammation and …, 2020 - Springer
Receptor activator of NF-κB (RANK) ligand (RANKL) induces the differentiation of monocyte/
macrophage–lineage cells into the bone–resorbing cells called osteoclasts. Because …

Progesterone and breast cancer

B Trabert, ME Sherman, N Kannan… - Endocrine …, 2020 - academic.oup.com
Synthetic progestogens (progestins) have been linked to increased breast cancer risk;
however, the role of endogenous progesterone in breast physiology and carcinogenesis is …

RANKL biology

N Takegahara, H Kim, Y Choi - Bone, 2022 - Elsevier
Since the receptor activator of nuclear factor-kappa B ligand (RANKL), its cognate receptor
activator of nuclear factor-kappa B (RANK), and the decoy receptor osteoprotegerin (OPG) …

RANKL/RANK/OPG system beyond bone remodeling: involvement in breast cancer and clinical perspectives

M Infante, A Fabi, F Cognetti, S Gorini, M Caprio… - Journal of Experimental …, 2019 - Springer
Abstract RANKL/RANK/OPG system consists of three essential signaling molecules: i) the
receptor activator of nuclear factor (NF)-kB-ligand (RANKL), ii) the receptor activator of NF …

Hormone replacement therapy after oophorectomy and breast cancer risk among BRCA1 mutation carriers

J Kotsopoulos, J Gronwald, BY Karlan… - JAMA …, 2018 - jamanetwork.com
Importance Prophylactic bilateral salpingo-oophorectomy is recommended
forBRCA1mutation carriers to prevent ovarian cancer. Whether or not hormone replacement …